ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Ann Thorac Surg 2009;88:1745-1748. doi:10.1016/j.athoracsur.2009.08.010
© 2009 The Society of Thoracic Surgeons
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Akinori Iwasaki
Right arrow Permission Requests
Google Scholar
Right arrow Articles by Obuchi, T.
Right arrow Articles by Iwasaki, A.
PubMed
Right arrow Articles by Obuchi, T.
Right arrow Articles by Iwasaki, A.
Related Collections
Right arrow Lung - cancer

Original Articles: General Thoracic

Clinical Outcome After Pulmonary Resection for Lung Cancer Patients on Hemodialysis

Toshiro Obuchi, MD*, Wakako Hamanaka, MD, Yasuhiro Yoshida, MD, Jun Yanagisawa, MD, Daisuke Hamatake, MD, Takeshi Shiraishi, MD, Akinori Iwasaki, MD

Department of Thoracic, Breast, Endocrine, and Pediatric Surgery, Fukuoka University Hospital, Fukuoka, Japan

Accepted for publication August 6, 2009.

* Address correspondence to Dr Obuchi, Jonan-ku, Nanakuma, 7 chome, 45-1, Fukuoka, 814-0180, Japan (Email: tobuchi{at}fukuoka-u.ac.jp).

Background: The number of operations for patients with malignant tumors receiving long-term hemodialysis has been increasing; however, there are only few reports about pulmonary resection for the patients with lung cancer.

Methods: Between 1995 and 2009, 11 hemodialysis patients (6 men, 5 women; mean age, 66.4 years) with non-small cell lung cancer underwent pulmonary resection at our institution. We retrospectively evaluated their postoperative clinical outcomes and long-term results.

Results: The underlying kidney conditions included nephrosclerosis in 3, diabetic nephropathy in 3, glomerulonephritis in 1, and polycystic kidney in 1; 3 patients had undergone nephrectomy. The median duration of hemodialysis preoperatively was 5.0 years. Three patients had been treated for previous carcinoma. The histopathologic diagnoses were adenocarcinoma in 9 patients and squamous cell carcinoma in 2. Procedures included lobectomy in 9, pneumonectomy in 1, and wedge resection in 1. There were no in-hospital deaths. Postoperative morbidity included 2 cases of pneumonia and 1 of chylothorax. At the time of our investigation, 6 patients were dead; 2 of cancer and 4 of noncancer causes. The overall 5-year survival rate of 11 patients was 28.0%.

Conclusions: Hemodialysis is not a contraindication to lung resection, despite the high morbidity rate. Surgical treatments, including lobectomy, remain one of effective treatments for patients on hemodialysis with lung cancer.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2009 by The Society of Thoracic Surgeons.